PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
49.84
+0.29 (0.59%)
Jun 27, 2025, 4:00 PM - Market closed
PTC Therapeutics Stock Forecast
Stock Price Forecast
According to 14 professional analysts, the 12-month price target for PTC Therapeutics stock ranges from a low of $40 to a high of $112. The average analyst price target of $63.57 forecasts a 27.55% increase in the stock price over the next year.
Price Target: $63.57 (+27.55%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PTC Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 5 | 6 | 6 | 6 | 6 | 6 |
| Hold | 3 | 2 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 13 | 13 | 13 | 13 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +60.51% | Jun 17, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $68 → $74 | Buy | Maintains | $68 → $74 | +48.48% | May 27, 2025 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $55 → $68 | Hold → Strong Buy | Upgrades | $55 → $68 | +36.44% | May 9, 2025 |
| Barclays | Barclays | Hold Maintains $56 → $42 | Hold | Maintains | $56 → $42 | -15.73% | May 8, 2025 |
| Baird | Baird | Buy Maintains $70 → $66 | Buy | Maintains | $70 → $66 | +32.42% | May 7, 2025 |
Financial Forecast
Revenue This Year
1.79B
from 806.78M
Increased by 121.50%
Revenue Next Year
871.34M
from 1.79B
Decreased by -51.24%
EPS This Year
5.99
from -4.73
EPS Next Year
-2.97
from 5.99
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.9B | 1.0B | 2.4B |
| Avg | 1.8B | 871.3M | 1.1B |
| Low | 1.6B | 708.7M | 816.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 140.5% | -43.0% | 170.4% |
| Avg | 121.5% | -51.2% | 31.2% |
| Low | 103.6% | -60.3% | -6.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.57 | -0.64 | 2.07 | ||
| Avg | 5.99 | -2.97 | -0.65 | ||
| Low | -4.56 | -6.99 | -4.17 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.